Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-036085)

Filing Details

Accession Number:: 0001209191-22-036085
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-10 18:24:26
Reporting Period:: 2022-06-08

Accepted Time:: 2022-06-10 18:24:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636282	Aeglea Biotherapeutics Inc.	AGLE	Pharmaceutical Preparations (2834)	464312787

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791413	Conick Michael Jr. Hanley	C/O Aeglea Biotherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX 78746	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-06-08	28,200	$0.71	36,200	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.